Company · CIK 0002091349 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
First Tracks Biotherapeutics, Inc. · TRAX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:05 pm EDT | John A OrwinDirector | 1,300 | — | — | 17,995 | — | |
| Sep 2, 2026 SForm 4 → | Sep 4, 4:25 pm EDT | J. Anthony WareDirector | 39,265 | $44.78 | $1,758,145 | 15,660 | −71.5% | |
| Sep 2, 2026 MForm 4 → | Sep 4, 4:25 pm EDT | J. Anthony WareDirector | 39,265 | $5.74 | $225,381 | 54,925 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 17, 4:05 pm EDT | John A OrwinDirector | 1,300 | — | — | 0 | — | |
| Sep 2, 2026 MForm 4 → | Sep 4, 4:25 pm EDT | J. Anthony WareDirector | 39,265 | — | — | 0 | — | |
| Aug 15, 2026 AForm 4 → | Aug 18, 4:05 pm EDT | Benjamin StoneChief Business Officer | 60,492 | — | — | 137,651 | — | |
| Aug 15, 2026 AForm 4 → | Aug 18, 4:05 pm EDT | Paul F. LizzulChief Medical Officer | 60,492 | — | — | 137,651 | — | |
| Aug 15, 2026 AForm 4 → | Aug 18, 4:05 pm EDT | Daniel FagaPresident, CEO, Director | 193,575 | — | — | 440,485 | — | |
| Aug 2, 2026 AForm 4 → | Aug 5, 6:26 pm EDT | Benjamin StoneChief Business Officer | 60,492 | — | — | 77,159 | — | late |
| Aug 2, 2026 AForm 4 → | Aug 5, 6:25 pm EDT | Paul F. LizzulChief Medical Officer | 60,492 | — | — | 77,159 | — | late |
| Aug 2, 2026 AForm 4 → | Aug 5, 6:24 pm EDT | Daniel FagaPresident, CEO, Director | 193,576 | — | — | 387,156 | — | late |